Penzes noted that initial clinical trials would involve participants with Phelan-McDermid syndrome and if successful, could eventually expand to include patients with other types of ASD
PlexusDx provides weekly check-ins to track progress
For patients, the message is mixed but useful
Ethical Approval This study was approved by the Institutional Animal Care and Use Committee at the Animal Center, Beijing Eastern Biotech, Co., Ltd
Jeremy W Tomlinson, Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK
This extra receptor activity may help increase energy expenditure and fat metabolism, which is one reason retatrutide is being studied as a possible next step beyond dual agonist therapies